Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Herbert Laboratories was a specialized pharmaceutical company focused on the development and commercialization of dermatological products. Founded by G.S. Herbert, the company established itself as a leader in topical skin treatments during the mid-20th century. In 1986, Allergan acquired the company from SmithKline Beckman for approximately $82 million to bolster its presence in the dermatology market. The acquisition brought several key products into Allergan's portfolio, including Fluoroplex for actinic keratosis and Erymax for acne. Following years of integration and subsequent corporate mergers, the legacy of Herbert Laboratories now resides within AbbVie's dermatology business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Herbert Laboratories.